4.6 Article

Medication overuse headache

Related references

Note: Only part of the references are listed.
Review Clinical Neurology

Non-invasive vagus nerve stimulation for prevention of migraine: The multicenter, randomized, double-blind, sham-controlled PREMIUM II trial

Umer Najib et al.

Summary: This study evaluates the efficacy and safety of non-invasive vagus nerve stimulation for migraine prevention. The results suggest clinical utility of this therapy for migraine prevention, particularly for patients with aura. The safety and tolerability profile of this treatment is well-established.

CEPHALALGIA (2022)

Article Clinical Neurology

Behavioural intervention in medication overuse headache: A concealed double-blind randomized controlled trial

Judith A. Pijpers et al.

Summary: This study evaluated the efficacy of behavioral intervention during medication withdrawal therapy. The results suggest that behavioral intervention by a headache nurse can reduce acute medication use during and shortly after the intervention. Further research is needed to determine the long-term effects.

EUROPEAN JOURNAL OF NEUROLOGY (2022)

Article Genetics & Heredity

Genome-wide analysis of 102,084 migraine cases identifies 123 risk loci and subtype-specific risk alleles

Heidi Hautakangas et al.

Summary: This study identified 123 susceptibility loci for migraine through genome-wide association analyses and implicated neurovascular mechanisms in its pathophysiology. Subtype analyses revealed risk loci specific for migraine with or without aura, as well as shared risk variants. The findings highlight the importance of both vascular and central nervous system tissue/cell types in the genetic underpinning of migraine.

NATURE GENETICS (2022)

Article Clinical Neurology

A prolactin-dependent sexually dimorphic mechanism of migraine chronification

Daigo Ikegami et al.

Summary: The study revealed a sexually dimorphic mechanism of migraine progression involving down-regulation of PRLR-L and increased signaling of circulating prolactin at PRLR-S. These findings suggest potential for novel sex-specific therapies, such as gene editing through nasal delivery of CRISPR/Cas9 constructs, to target migraine pain specifically in females.

CEPHALALGIA (2022)

Article Clinical Neurology

Validation of diagnostic ICHD-3 criteria for menstrual migraine

Iris E. Verhagen et al.

Summary: Self-reported menstrual migraine diagnosis has extremely poor accuracy, and pure menstrual migraine is rare. Women with menstrual migraine have longer attack duration and increased triptan intake during perimenstrual attacks.

CEPHALALGIA (2022)

Review Clinical Neurology

The Global Campaign turns 18: a brief review of its activities and achievements

Timothy J. Steiner et al.

Summary: The Global Campaign against Headache, in collaboration with the World Health Organization (WHO), has been launched to review its activities and achievements over the past 18 years. The campaign has focused on strategic objectives, partnerships, project management, knowledge acquisition, and awareness generation, resulting in evidence-based proposals for change justified by cost-effectiveness analysis.

JOURNAL OF HEADACHE AND PAIN (2022)

Review Clinical Neurology

The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates

Lars Jacob Stovner et al.

Summary: This article summarizes the epidemiological studies of headache disorders globally, finding that headache disorders remain highly prevalent worldwide, and identifies methodological factors explaining the large variation between study findings. While migraine prevalence estimates increased over time, estimates for all headache types varied between world regions.

JOURNAL OF HEADACHE AND PAIN (2022)

Article Clinical Neurology

Patient-Centered Treatment of Chronic Migraine With Medication Overuse A Prospective, Randomized, Pragmatic Clinical Trial

Todd J. Schwedt et al.

Summary: This study aims to determine whether migraine preventive therapy without switching or limiting the frequency of overused medication is noninferior to migraine preventive therapy with switching to an alternative medication that could be used on <= 2 d/wk.

NEUROLOGY (2022)

Article Geriatrics & Gerontology

Characteristics and comorbidities of headache in patients over 50 years of age: a cross-sectional study

Mansoureh Togha et al.

Summary: Headache is a common symptom in older adults, with different diagnostic and treatment methods compared to younger individuals. Medication-overuse headache patients are more prone to hypothyroidism and gastrointestinal problems, while depression and obstructive sleep apnea are more common in these patients.

BMC GERIATRICS (2022)

Article Clinical Neurology

The prevalence of headache disorders in children and adolescents in Iran: a schools-based study

Mansoureh Togha et al.

Summary: This national study in Iran examined the prevalence of headache disorders among children and adolescents. The results showed that headache disorders are common in this population, with undifferentiated headache accounting for a significant portion of cases. The study also found an increasing prevalence of probable medication-overuse headache with age.

CEPHALALGIA (2022)

Article Clinical Neurology

Clinical characteristics of medication-overuse headache according to the class of acute medication: A cross-sectional multicenter study

Sun-Young Oh et al.

Summary: The clinical features of patients with medication-overuse headache (MOH) differ according to the class of overused medications. Patients who overused multiple drug classes reported more frequent use of acute medications and fewer crystal-clear days, as well as shorter intervals from chronic daily headache to the onset of MOH and more emergency room visits. These findings contribute to the understanding of the clinical characteristics and pathophysiology of MOH.

HEADACHE (2022)

Review Clinical Neurology

Applying a biopsychosocial model to migraine: rationale and clinical implications

Chiara Rosignoli et al.

Summary: Migraine is a complex condition influenced by genetic, biological, environmental, psychological, and social factors. The application of a biopsychosocial approach in the management of migraine may lead to better therapeutic outcomes.

JOURNAL OF HEADACHE AND PAIN (2022)

Article Neurosciences

Medication overuse headache associated with decreased dopamine transporter availability in the medial but not in the lateral orbitofrontal cortex: a 11CFT PET/MR study

Huanxian Liu et al.

Summary: This study aimed to investigate the dysfunction of the mesocorticolimbic dopamine system in medication overuse headache (MOH) patients. The results showed that MOH patients had decreased dopamine transporter (DAT) availability in the medial orbitofrontal cortex (OFC), indicating compensatory downregulation due to low dopamine signaling. This finding provides a new perspective for understanding the pathogenesis of MOH.

INTERNATIONAL JOURNAL OF NEUROSCIENCE (2022)

Article Clinical Neurology

The prevalence of primary headache disorders in children and adolescents in Zambia: a schools-based study

Nfwama Kawatu et al.

Summary: This study found that headache disorders are prevalent among young people in Zambia, with migraine being the most common. There were diagnostic uncertainties, especially in distinguishing between migraine and undifferentiated headache among participants reporting headache durations of less than 2 hours.

JOURNAL OF HEADACHE AND PAIN (2022)

Article Environmental Sciences

A Preliminary Analysis on the Feasibility and Short-Term Efficacy of a Phase-III RCT on Mindfulness Added to Treatment as Usual for Patients with Chronic Migraine and Medication Overuse Headache

Licia Grazzi et al.

Summary: This preliminary analysis compares the feasibility and short-term efficacy of mindfulness as an add-on to treatment for chronic migraine and medication overuse headache. The results suggest that adding mindfulness therapy to the usual treatment leads to better outcomes in terms of headache frequency and medication intake.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)

Article Clinical Neurology

Sex differences in prevalence of migraine trigger factors: A cross-sectional study

Daphne S. van Casteren et al.

Summary: The study showed that females report migraine trigger factors more frequently than males, with menstruation, stress, and bright light being the top triggers for women. Women tend to report more triggers and have a lower migraine threshold compared to men, potentially due to hormonal changes.

CEPHALALGIA (2021)

Article Clinical Neurology

Anodal transcranial direct current stimulation in chronic migraine and medication overuse headache: A pilot double-blind randomized sham-controlled trial

R. De Icco et al.

Summary: This study suggests a possible role for tDCS in the treatment of chronic migraine (CM) and medication overuse headache (MOH). The clinical improvement observed in patients with CM and MOH is associated with a potentiation of EEG alpha rhythm.

CLINICAL NEUROPHYSIOLOGY (2021)

Article Clinical Neurology

Burden of increasing opioid use in the treatment of migraine: Results from the Migraine in America Symptoms and Treatment Study

Richard B. Lipton et al.

Summary: This study aimed to assess factors associated with the frequency of self-reported prescription opioid use in persons with migraine. The analysis revealed that increasing use of prescription opioids is associated with male gender, chronic migraine, more severe disability, anxiety and depression, poor acute treatment optimization, and treatment in a pain clinic.

HEADACHE (2021)

Article Clinical Neurology

Headache characteristics and burden from chronic migraine with medication overuse headache: Cross-sectional observations from the Medication Overuse Treatment Strategy trial

Todd J. Schwedt et al.

Summary: The study described headache characteristics, medication use, disability, and quality of life in patients with chronic migraine (CM) and medication overuse headache (MOH) from the United States. Findings showed a significant burden on patients with CM and MOH, with higher headache frequency associated with greater impact on functioning, pain interference, and quality of life.

HEADACHE (2021)

Article Clinical Neurology

Efficacy, tolerability, and safety of eptinezumab in patients with a dual diagnosis of chronic migraine and medication-overuse headache: Subgroup analysis of PROMISE-2

Hans-Christoph Diener et al.

Summary: The study evaluated the efficacy and tolerability of Eptinezumab in patients with dual diagnosis of CM and MOH, showing that Eptinezumab treatment led to greater reductions in monthly migraine days, higher responder rates, and fewer patients meeting CM and MOH criteria.

HEADACHE (2021)

Article Medicine, General & Internal

Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial

Robert Croop et al.

Summary: Rimegepant was found to be effective for preventive treatment of migraine compared to placebo, with tolerability similar to that of placebo and no unexpected or serious safety issues noted.

LANCET (2021)

Review Clinical Neurology

Sex Differences in Response to Triptans A Systematic Review and Meta-analysis

Daphne S. van Casteren et al.

Summary: Our study found that men had a lower risk for headache recurrence and adverse events in response to triptans, as well as lower drug exposure compared to women. Despite higher drug exposure, women had higher headache recurrence rates possibly due to sex hormonal changes in longer attack duration.

NEUROLOGY (2021)

Review Clinical Neurology

Conditioned pain modulation-A comprehensive review

Shankar Ramaswamy et al.

Summary: Conditioned pain modulation (CPM) is a centrally processed measure of the net effect of the descending pain pathway, which could potentially serve as a biomarker for pain. Various factors influence CPM paradigms, including patient-related factors and methodological variables, highlighting the importance of establishing consistent methodologies for measuring CPM to enhance its robustness.

NEUROPHYSIOLOGIE CLINIQUE-CLINICAL NEUROPHYSIOLOGY (2021)

Article Clinical Neurology

Depression, Anxiety, Stress, and Health-Related Quality of Life Among Patients With Medication Overuse Headache in a Tertiary Headache Center: A Cross-Sectional Study

Marina Ljubisavljevic et al.

Summary: This study found that Medication overuse headache (MOH) has a significant negative impact on the personal, family, and social life of patients and is associated with depression, anxiety, and stress. Patients' age, duration of MOH, presence of comorbidities, and adverse effects of physical, emotional, and social dysfunction are particularly important contributors to the negative effects of MOH.

JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES (2021)

Article Neurosciences

Kappa opioid receptor activation in the amygdala disinhibits CRF neurons to generate pain-like behaviors

Matthew Hein et al.

Summary: The activation of KOR in the CeA increases activity of amygdala CRF neurons through synaptic disinhibition, leading to averse-affective pain-like behaviors.

NEUROPHARMACOLOGY (2021)

Article Clinical Neurology

Determinants of pain interference and headache impact in patients who have chronic migraine with medication overuse: Results from the MOTS trial

Todd J. Schwedt et al.

Summary: Chronic migraine with medication overuse leads to severe negative consequences on an individual's life, with depression symptoms being the strongest predictor of pain interference and headache impact.

CEPHALALGIA (2021)

Article Clinical Neurology

E-diary use in clinical headache practice: A prospective observational study

Daphne S. van Casteren et al.

Summary: The study showed that the E-diary is useful in diagnosing migraine and can help patients accurately record the number of headache and migraine days, providing reliable information for healthcare providers.

CEPHALALGIA (2021)

Review Clinical Neurology

The Evolution of Medication Overuse Headache: History, Pathophysiology and Clinical Update

Christina Sun-Edelstein et al.

Summary: Medication overuse headache (MOH) is a common secondary headache disorder caused by frequent and excessive use of medications for acute headache treatment, potentially facilitating trigeminal nociceptive process through up-regulation of the CGRP system. Recognizing and preventing its development is crucial in migraine management, with ongoing debates over MOH diagnosis, pathogenesis, and treatment strategies. The efficacy of anti-CGRP monoclonal antibodies in MOH suggests potential alternative treatments without the need for detoxification.

CNS DRUGS (2021)

Article Clinical Neurology

Reference programme: diagnosis and treatment of headache disorders and facial pain. Danish Headache Society, 3rd edition, 2020

Henrik W. Schytz et al.

Summary: The Danish Headache Society has launched a third version of the guidelines for the diagnosis, organization, and treatment of the most common types of headaches and facial pain, aiming to educate and advocate for the needs of patients. The guidelines provide information on examining and diagnosing headache patients, organizing headache treatment, as well as characteristics, diagnosis, and treatment for each common type of headache disorders.

JOURNAL OF HEADACHE AND PAIN (2021)

Article Clinical Neurology

Association between suicidal risks and medication-overuse headache in chronic migraine: a cross-sectional study

Yen-Feng Wang et al.

Summary: The study found that in chronic migraine patients, comorbid medication-overuse headache (MOH) is associated with an increased risk of suicidal ideation and prior suicide attempt.

JOURNAL OF HEADACHE AND PAIN (2021)

Review Clinical Neurology

Medication overuse and drug addiction: a narrative review from addiction perspective

Tatiane Teru Takahashi et al.

Summary: Chronic headaches are common in migraineurs and can progress to medication overuse headache (MOH). MOH is caused by overuse of painkillers or other medications. While head pain symptoms associated with medication overuse generally improve after stopping regular medication use, behavioral issues such as drug dependence may still persist.

JOURNAL OF HEADACHE AND PAIN (2021)

Review Medicine, Research & Experimental

Understanding the genetics and neurobiological pathways behind addiction (Review)

Alexandra Popescu et al.

Summary: The occurrence of addiction is influenced by various factors such as genetics, environment, intrinsic factors, extrinsic factors, and the nature of addictive substances. The dopamine-mesolimbic motivation-reward-reinforcement cycle is the most consistent physiological theory in addiction, with addictive substances sharing the common property of being dopamine-agonists but each having individual mechanisms and psychoactive potentials.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2021)

Article Medicine, General & Internal

Tension-type headache

Sait Ashina et al.

Summary: Tension-type headache is the most prevalent neurological disorder characterized by recurrent headaches of mild to moderate intensity, bilateral location, and no aggravation by routine physical activity. The mainstay of treatment is pharmacological therapy, with recommended preventive treatments including certain medications and non-pharmacological therapies. Despite the widespread prevalence and associated disability, little progress has been made in the field of tension-type headache due to lack of attention and resource allocation.

NATURE REVIEWS DISEASE PRIMERS (2021)

Article Clinical Neurology

The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice

Jessica Ailani et al.

Summary: This update aims to incorporate recent research findings, expert consensus, and patient perspectives into updated guidance on the use of new acute and preventive treatments for migraine in adults. It provides practical recommendations based on expanded evidence base and emerging expert consensus, in the absence of a formal guideline.

HEADACHE (2021)

Article Clinical Neurology

Comparing Perimenstrual and Nonperimenstrual Migraine Attacks Using an e-Diary

Daphne S. van Casteren et al.

Summary: The study compared characteristics of perimenstrual and nonperimenstrual migraine attacks in women, finding that perimenstrual attacks were associated with longer duration, higher recurrence risk, increased triptan use, higher headache intensity, decreased pain coping, more pronounced photophobia and phonophobia. Additionally, women with menstrually related migraine are at risk of medication overuse in the long term treatment process.

NEUROLOGY (2021)

Article Medicine, General & Internal

Atogepant for the Preventive Treatment of Migraine

Jessica Ailani et al.

Summary: Oral atogepant once daily was effective in reducing the number of migraine days and headache days over a period of 12 weeks, but may cause adverse events such as constipation and nausea. Longer and larger trials are needed to determine the effect and safety of atogepant for migraine prevention.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Clinical Neurology

Medication overuse in a subgroup analysis of phase 3 placebo-controlled studies of galcanezumab in the prevention of episodic and chronic migraine

David W. Dodick et al.

Summary: The study demonstrates that galcanezumab is effective in preventing episodic and chronic migraine in patients with acute medication overuse, significantly reducing the number of monthly migraine days and medication overuse rates compared to placebo.

CEPHALALGIA (2021)

Editorial Material Clinical Neurology

Medication overuse headache: The trouble with prevalence estimates

Elizabeth W. Loder et al.

CEPHALALGIA (2020)

Article Clinical Neurology

Monitoring chronic headache and medication-overuse headache prevalence in Denmark

Maria Lurenda Westergaard et al.

CEPHALALGIA (2020)

Article Clinical Neurology

The prevalence of primary headache disorders in Saudi Arabia: a cross-sectional population-based study

Mohammed Al Jumah et al.

JOURNAL OF HEADACHE AND PAIN (2020)

Article Clinical Neurology

European Academy of Neurology guideline on the management of medication-overuse headache

H. C. Diener et al.

EUROPEAN JOURNAL OF NEUROLOGY (2020)

Review Clinical Neurology

Brain Structural and Functional Imaging Findings in Medication-Overuse Headache

Catherine D. Chong

FRONTIERS IN NEUROLOGY (2020)

Article Clinical Neurology

Comparison of 3 Treatment Strategies for Medication Overuse Headache A Randomized Clinical Trial

Louise Ninett Carlsen et al.

JAMA NEUROLOGY (2020)

Article Clinical Neurology

The prevalence of headache disorders in children and adolescents in Lithuania: a schools-based study

Diana Genc et al.

JOURNAL OF HEADACHE AND PAIN (2020)

Review Neurosciences

An Emerging Role for Prolactin in Female-Selective Pain

Yanxia Chen et al.

TRENDS IN NEUROSCIENCES (2020)

Article Clinical Neurology

The prevalence of headache disorders in children and adolescents in Mongolia: a nationwide schools-based study

Otgonbayar Luvsannorov et al.

JOURNAL OF HEADACHE AND PAIN (2020)

Article Clinical Neurology

The prevalence of headache disorders in children and adolescents in Ethiopia: a schools-based study

Yared Zenebe Zewde et al.

JOURNAL OF HEADACHE AND PAIN (2020)

Article Clinical Neurology

The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study

Stephen D. Silberstein et al.

JOURNAL OF HEADACHE AND PAIN (2020)

Review Medicine, General & Internal

Migraine

Messoud Ashina

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Substance Abuse

Severity of Analgesic Dependence and Medication-overuse Headache

Christofer Lundqvist et al.

JOURNAL OF ADDICTION MEDICINE (2019)

Article Clinical Neurology

Pathophysiology, prevention, and treatment of medication overuse headache

Hans-Christoph Diener et al.

LANCET NEUROLOGY (2019)

Article Medicine, General & Internal

Rimegepant, an Oral Calcitonin Gene-Related Peptide Receptor Antagonist, for Migraine

Richard B. Lipton et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Review Clinical Neurology

Migraine Progression: A Systematic Review

Dawn C. Buse et al.

HEADACHE (2019)

Article Medicine, General & Internal

Ubrogepant for the Treatment of Migraine

David W. Dodick et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Editorial Material Clinical Neurology

De-Stigmatizing Migraine - With Words

William B. Young

HEADACHE (2018)

Article Biochemistry & Molecular Biology

Molecular genetic overlap between migraine and major depressive disorder

Yuanhao Yang et al.

EUROPEAN JOURNAL OF HUMAN GENETICS (2018)

Review Clinical Neurology

The big CGRP flood - sources, sinks and signalling sites in the trigeminovascular system

Karl Messlinger

JOURNAL OF HEADACHE AND PAIN (2018)

Review Clinical Neurology

Medication-overuse headache: a widely recognized entity amidst ongoing debate

Nicolas Vandenbussche et al.

JOURNAL OF HEADACHE AND PAIN (2018)

Article Multidisciplinary Sciences

Analysis of shared heritability in common disorders of the brain

Verneri Anttila et al.

SCIENCE (2018)

Review Clinical Neurology

The Global Burden of Headache

Deanna Saylor et al.

SEMINARS IN NEUROLOGY (2018)

Review Clinical Neurology

Triggers, Protectors, and Predictors in Episodic Migraine

Michael J. Marmura

CURRENT PAIN AND HEADACHE REPORTS (2018)

Review Behavioral Sciences

Pituitary Hormones and Orofacial Pain

Gregory Dussor et al.

FRONTIERS IN INTEGRATIVE NEUROSCIENCE (2018)

Article Clinical Neurology

National awareness campaign to prevent medication-overuse headache in Denmark

Louise Ninett Carlsen et al.

CEPHALALGIA (2018)

Review Clinical Neurology

Serotonergic mechanisms in the migraine brain - a systematic review

Marie Deen et al.

CEPHALALGIA (2017)

Article Clinical Neurology

Calcitonin gene-related peptide and pain: a systematic review

Wendy Sophie Schou et al.

JOURNAL OF HEADACHE AND PAIN (2017)

Article Clinical Neurology

Treatment of withdrawal headache in patients with medication overuse headache: a pilot study

Sabina Cevoli et al.

JOURNAL OF HEADACHE AND PAIN (2017)

Article Clinical Neurology

Nonpainful remote electrical stimulation alleviates episodic migraine pain

David Yarnitsky et al.

NEUROLOGY (2017)

Review Clinical Neurology

Medication overuse headache An entrenched idea in need of scrutiny

Ann I. Scher et al.

NEUROLOGY (2017)

Review Clinical Neurology

Treatment of medication-overuse headache: A systematic review

Chia-Chun Chiang et al.

CEPHALALGIA (2016)

Article Clinical Neurology

Psychopathological comorbidities in medication-overuse headache: a multicentre clinical study

P. Sarchielli et al.

EUROPEAN JOURNAL OF NEUROLOGY (2016)

Article Clinical Neurology

Disability, anxiety and depression in patients with medication-overuse headache in primary care - the BIMOH study

E. S. Kristoffersen et al.

EUROPEAN JOURNAL OF NEUROLOGY (2016)

Article Clinical Neurology

Gray matter changes related to medication overuse in patients with chronic migraine

Tzu-Hsien Lai et al.

CEPHALALGIA (2016)

Article Clinical Neurology

Headache, depression and anxiety: associations in the Eurolight project

Christian Lampl et al.

JOURNAL OF HEADACHE AND PAIN (2016)

Article Clinical Neurology

The prevalence of primary headache disorders in Ethiopia

Mehila Zebenigus et al.

JOURNAL OF HEADACHE AND PAIN (2016)

Article Clinical Neurology

Risk of medication overuse headache across classes of treatments for acute migraine

Kristian Thorlund et al.

JOURNAL OF HEADACHE AND PAIN (2016)

Article Clinical Neurology

Biofeedback in the prophylactic treatment of medication overuse headache: a pilot randomized controlled trial

Marialuisa Rausa et al.

JOURNAL OF HEADACHE AND PAIN (2016)

Review Clinical Neurology

Medication-overuse headache: risk factors, pathophysiology and management

Hans-Christoph Diener et al.

NATURE REVIEWS NEUROLOGY (2016)

Article Clinical Neurology

Headache disorders and public ill-health in India: prevalence estimates in Karnataka State

Girish B. Kulkarni et al.

JOURNAL OF HEADACHE AND PAIN (2015)

Article Clinical Neurology

The prevalence of primary headache disorders in Nepal: a nationwide population-based study

Kedar Manandhar et al.

JOURNAL OF HEADACHE AND PAIN (2015)

Article Clinical Neurology

Correlation Between Life Events and Quality of Life in Patients with Medication-Overuse Headache

Ebru Altintas et al.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY (2015)

Article Clinical Neurology

Medication overuse headache - An under-diagnosed problem in shunted idiopathic intracranial hypertension patients

Ruth-Mary deSouza et al.

BRITISH JOURNAL OF NEUROSURGERY (2015)

Article Clinical Neurology

Brief intervention for medication-overuse headache in primary care. The BIMOH study: a double-blind pragmatic cluster randomised parallel controlled trial

Espen Saxhaug Kristoffersen et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)

Editorial Material Clinical Neurology

Can we know the prevalence of MOH?

T. J. Steiner

CEPHALALGIA (2014)

Review Clinical Neurology

Medication Overuse in Children and Adolescents

Amy A. Gelfand et al.

CURRENT PAIN AND HEADACHE REPORTS (2014)

Article Clinical Neurology

Sodium valproate in migraine without aura and medication overuse headache: A randomized controlled trial

Paola Sarchielli et al.

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2014)

Review Clinical Neurology

Clinical Aspects of Medication Overuse Headaches

Arnaldo Neves Da Silva et al.

HEADACHE (2014)

Article Clinical Neurology

Medication Overuse Headache

Signe B. Munksgaard et al.

HEADACHE (2014)

Article Clinical Neurology

Should we educate about the risks of medication overuse headache?

James T. F. Lai et al.

JOURNAL OF HEADACHE AND PAIN (2014)

Review Clinical Neurology

Migraine and Triggers: Post Hoc Ergo Propter Hoc?

Jan Hoffmann et al.

CURRENT PAIN AND HEADACHE REPORTS (2013)

Article Clinical Neurology

The prevalence of primary headache disorders in Russia: A countrywide survey

I. Ayzenberg et al.

CEPHALALGIA (2012)

Review Clinical Neurology

Dependent Behavior in Patients with Medication-Overuse Headache

Jong-Ling Fuh et al.

CURRENT PAIN AND HEADACHE REPORTS (2012)

Article Clinical Neurology

The cost of headache disorders in Europe: the Eurolight project

M. Linde et al.

EUROPEAN JOURNAL OF NEUROLOGY (2012)

Article Clinical Neurology

Genomic expression patterns in medication overuse headaches

Andrew D. Hershey et al.

CEPHALALGIA (2011)

Article Clinical Neurology

Epidemiology of medication overuse headache in the general Swedish population

Pernilla Jonsson et al.

CEPHALALGIA (2011)

Article Clinical Neurology

Persistent medication-induced neural adaptations, descending facilitation, and medication overuse headache

Milena De Felice et al.

CURRENT OPINION IN NEUROLOGY (2011)

Article Clinical Neurology

Basal cutaneous pain threshold in headache patients

Maurizio Zappaterra et al.

JOURNAL OF HEADACHE AND PAIN (2011)

Article Clinical Neurology

Abnormal cortical responses to somatosensory stimulation in medication-overuse headache

Gianluca Coppola et al.

BMC NEUROLOGY (2010)

Article Clinical Neurology

Cortical hyperexcitability and mechanism of medication-overuse headache

Weera Supornsilpchai et al.

CEPHALALGIA (2010)

Review Clinical Neurology

Medication overuse headache: a critical review of end points in recent follow-up studies

Knut Hagen et al.

JOURNAL OF HEADACHE AND PAIN (2010)

Article Clinical Neurology

Medication overuse as a cause of chronic headache in shunted hydrocephalus patients

L. Willer et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)

Article Clinical Neurology

Psychiatric comorbidity and suicide risk in patients with chronic migraine

Maurizio Pompili

Neuropsychiatric Disease and Treatment (2010)

Review Clinical Neurology

Migraine headache in perimenopausal and menopausal women

E. Anne MacGregor

CURRENT PAIN AND HEADACHE REPORTS (2009)

Review Clinical Neurology

Central Sensitization: A Generator of Pain Hypersensitivity by Central Neural Plasticity

Alban Latremoliere et al.

JOURNAL OF PAIN (2009)

Article Clinical Neurology

Non-pharmacological approaches to treating chronic migraine with medication overuse

F. Andrasik et al.

NEUROLOGICAL SCIENCES (2009)

Editorial Material Public, Environmental & Occupational Health

Disability and Disability-Adjusted Life Years: Not the Same

Scott D. Grosse et al.

PUBLIC HEALTH REPORTS (2009)

Article Clinical Neurology

Evidence of persistent central sensitization in chronic headaches: a multi-method study

Elena Filatova et al.

JOURNAL OF HEADACHE AND PAIN (2008)

Article Clinical Neurology

Headache with medication overuse: treatment strategies and proposals of relapse prevention

Licia Grazzi et al.

NEUROLOGICAL SCIENCES (2008)

Article Clinical Neurology

Emotional problems and prevalence of medication overuse in pediatric chronic daily headache

Ann Pakalnis et al.

JOURNAL OF CHILD NEUROLOGY (2007)

Review Clinical Neurology

Medication overuse headache: Biobehavioral issues and solutions

Alvin E. Lake

HEADACHE (2006)

Article Clinical Neurology

Analgesic overuse among subjects with headache, neck, and low-back pain

JA Zwart et al.

NEUROLOGY (2004)

Article Clinical Neurology

Out-patient detoxification in chronic migraine: comparison of strategies

AV Krymchantowski et al.

CEPHALALGIA (2003)